Gunnar Lindahl

Charlotte Larsson

Margaretha Stalhammar-Carlemalm

Thomas Areschoug

A polypeptide is described herein which comprises (a) the sequence of SEQ ID No. 2, (b) a variant of (a) which is capable of generating a protective immune response to, or (c) a fragment of (a) or (b) of at least 6 amino acids in length which is capable of generating a protective immune response to, in the manufacture of medicament for use as a vaccine against. A pharmaceutical composition for use in vaccinating againstor Group Bcomprises a polypeptide which comprises: (A) the amino acid sequence of SEQ ID No. 2, (B) a variant of (A) which is capable of conferring protective immunity toor Group B, or (C) a fragment of (A) or (B) of at least 6 amino acids in length which is capable of conferring protective immunity toor Group B

Growing community of inventors

Lund, Sweden

Charlotte Larsson